These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35042259)

  • 1. Nebulized Antibiotics for Healthcare- and Ventilator-Associated Pneumonia.
    Boisson M; Bouglé A; Sole-Lleonart C; Dhanani J; Arvaniti K; Rello J; Rouby JJ; Mimoz O;
    Semin Respir Crit Care Med; 2022 Apr; 43(2):255-270. PubMed ID: 35042259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of adjunctive nebulized colistin sulfate for multidrug-resistant Gram-negative bacteria pneumonia: a retrospective comparative cohort study.
    Bao XL; Tao T; Tang N; Wang YZ; Liao XQ; Huang LL; Ji JJ; Chen X
    Ann Palliat Med; 2022 Sep; 11(9):2939-2951. PubMed ID: 36217623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized control study of nebulized colistin as an adjunctive therapy in ventilator-associated pneumonia in pediatric postoperative cardiac surgical population.
    Bharathi KS; Bhat A; Pruthi G; Simha PP
    Ann Card Anaesth; 2022; 25(4):435-440. PubMed ID: 36254907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials.
    Monsel A; Torres A; Zhu Y; Pugin J; Rello J; Rouby JJ;
    Curr Opin Infect Dis; 2021 Apr; 34(2):156-168. PubMed ID: 33605620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives.
    Zhu Y; Monsel A; Roberts JA; Pontikis K; Mimoz O; Rello J; Qu J; Rouby JJ;
    Microorganisms; 2021 May; 9(6):. PubMed ID: 34072189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a systematic review and meta-analysis.
    Gu WJ; Wang F; Tang L; Bakker J; Liu JC
    Int J Antimicrob Agents; 2014 Dec; 44(6):477-85. PubMed ID: 25199968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance.
    Ghannam DE; Rodriguez GH; Raad II; Safdar A
    Eur J Clin Microbiol Infect Dis; 2009 Mar; 28(3):253-9. PubMed ID: 18752007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.
    Rattanaumpawan P; Lorsutthitham J; Ungprasert P; Angkasekwinai N; Thamlikitkul V
    J Antimicrob Chemother; 2010 Dec; 65(12):2645-9. PubMed ID: 20876621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study.
    Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB
    J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: a call for international guidelines.
    Solé-Lleonart C; Roberts JA; Chastre J; Poulakou G; Palmer LB; Blot S; Felton T; Bassetti M; Luyt CE; Pereira JM; Riera J; Welte T; Qiu H; Rouby JJ; Rello J;
    Clin Microbiol Infect; 2016 Apr; 22(4):359-364. PubMed ID: 26723563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial.
    Liu C; Zhang YT; Peng ZY; Zhou Q; Hu B; Zhou H; Li JG
    Chin Med J (Engl); 2017 May; 130(10):1196-1201. PubMed ID: 28485320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria.
    Choe J; Sohn YM; Jeong SH; Park HJ; Na SJ; Huh K; Suh GY; Jeon K
    Ther Adv Respir Dis; 2019; 13():1753466619885529. PubMed ID: 31680646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria.
    Tumbarello M; De Pascale G; Trecarichi EM; De Martino S; Bello G; Maviglia R; Spanu T; Antonelli M
    Chest; 2013 Dec; 144(6):1768-1775. PubMed ID: 23989805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
    Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
    Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients.
    Boisson M; Jacobs M; Grégoire N; Gobin P; Marchand S; Couet W; Mimoz O
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7331-9. PubMed ID: 25267660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two therapeutic approaches for the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter: a randomized clinical trial study.
    Khorvash F; Yaghoubi S; Farsaei S; Ataei B; Hakamifard A; Mohajeri F; Gudarzi M
    J Immunoassay Immunochem; 2020; 41(1):97-105. PubMed ID: 31777299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review.
    Karaiskos I; Gkoufa A; Polyzou E; Schinas G; Athanassa Z; Akinosoglou K
    Microorganisms; 2023 May; 11(6):. PubMed ID: 37374959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-drug versus combination antimicrobial therapy in critically ill patients with hospital-acquired pneumonia and ventilator-associated pneumonia due to Gram-negative pathogens: a multicenter retrospective cohort study.
    Barbier F; Dupuis C; Buetti N; Schwebel C; Azoulay É; Argaud L; Cohen Y; Hong Tuan Ha V; Gainnier M; Siami S; Forel JM; Adrie C; de Montmollin É; Reignier J; Ruckly S; Zahar JR; Timsit JF;
    Crit Care; 2024 Jan; 28(1):10. PubMed ID: 38172969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.